• Important Safety Information
• Prescribing Information

Once you have confirmed alpha₁-antitrypsin (AAT) deficiency* in your patient, you need the best resources to offer them the proper guidance.

Therapy Options While there is no cure for alpha1-antitrypsin (AAT) deficiency, there are a number of therapies available to your patient.	About ARALAST Find out how your patient could benefit from augmentation therapy with an alpha1-proteinase inhibitor.
Easy Start Sample Program Your patient may be eligible for a complimentary two-week sample supply of ARALAST.	Patient Education Kit Help your patient learn more about their condition, therapy options, and tips for day-to-day living with AAT deficiency.
ARALAST AATmosphere Our support program is available online and over the phone for Alphas and their families. Our team includes Registered Nurses, Alpha-1 Advocates, Insurance Specialists, and AATmosphere Representatives; they're all ready to answer any questions your patients might have.

Alpha1Health.com is here to help you manage many aspects of your AAT deficient patients. We invite you to visit other sections of our website to learn more.

Here are some good starting points:

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information